Phase Ib study of weekly mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) with weekly paclitaxelSESSA, C; TOSI, D; COCEANI, N et al.Annals of oncology. 2010, Vol 21, Num 6, pp 1315-1322, issn 0923-7534, 8 p.Article

Target Enzyme Activity as a Biomarker for ImmunosuppressionGLANDER, Petra; BUDDE, Klemens.Therapeutic drug monitoring. 2010, Vol 32, Num 3, pp 257-260, issn 0163-4356, 4 p.Conference Paper

Rash to the mTOR Inhibitor Everolimus Systematic Review and Meta-AnalysisRAMIREZ-FORT, Marigdalia K; CASE, Emily C; ROSEN, Alyx C et al.American journal of clinical oncology. 2014, Vol 37, Num 3, pp 266-271, issn 0277-3732, 6 p.Article

Stent elution rate determines drug deposition and receptor-mediated effectsTZAFRIRI, Abraham R; GROOTHUIS, Adam; SYLVESTER PRICE, G et al.Journal of controlled release. 2012, Vol 161, Num 3, pp 918-926, issn 0168-3659, 9 p.Article

Graft-versus-Host-Disease (GvHD): ein Update Teil 2: Prognose und Therapie der GvHD = Graft-versus-Host Disease (GvHD): an update · Part 2: Prognosis and therapy of GvHDTRAVNIK, R; BECKERS, M; WOLFF, D et al.Der Hautarzt. 2011, Vol 62, Num 3, pp 229-237, issn 0017-8470, 9 p.Article

mTOR Signaling Pathway and mTOR Inhibitors in Cancer TherapyGOMEZ-PINILLOS, Alejandro; FERRARI, Anna C.Hematology/oncology clinics of North America. 2012, Vol 26, Num 3, issn 0889-8588, vii, 483-505 [24 p.]Article

Characterization of Torin2, an ATP-Competitive Inhibitor of mTOR, ATM, and ATRQINGSONG LIU; CHUNXIAO XU; ERCAN, Dalia et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 8, pp 2574-2586, issn 0008-5472, 13 p.Article

Hematologic toxicities associated with mTOR inhibitors temsirolimus and everolimus in cancer patients: a systematic review and meta-analysisJIAN XU; DEYING TIAN.Current medical research and opinion. 2014, Vol 30, Num 1, pp 67-74, issn 0300-7995, 8 p.Article

Metabolic complications with the use of mTOR inhibitors for cancer therapySIVENDRAN, Shanthi; AGARWAL, Neeraj; GARTRELL, Benjamin et al.Cancer treatment reviews. 2014, Vol 40, Num 1, pp 190-196, issn 0305-7372, 7 p.Article

Therapy With m-TOR Inhibitors Decreases the Response to the Pandemic Influenza A H1 N1 Vaccine in Solid Organ Transplant RecipientsCORDERO, E; PEREZ-ORDONEZ, A; PACHON, J et al.American journal of transplantation (Print). 2011, Vol 11, Num 10, pp 2205-2213, issn 1600-6135, 9 p.Article

Everolimus: A New Treatment Option for Advanced Pancreatic Neuroendocrine TumorsTHOMPSON, Lisa A; KIM, Miryoung; WENGER, Sarah D et al.The Annals of pharmacotherapy. 2012, Vol 46, Num 9, pp 1212-1219, issn 1060-0280, 8 p.Article

VEGF Secretion by Neuroendocrine Tumor Cells Is Inhibited by Octreotide and by Inhibitors of the PI3K/AKT/mTOR PathwayVILLAUME, Karine; BLANC, Martine; GOUYSSE, Géraldine et al.Neuroendocrinology (Basel). 2010, Vol 91, Num 3, pp 268-278, issn 0028-3835, 11 p.Article

Skin Cancer in Organ Transplant Recipients : Where Do We Stand Today?ULRICH, C; KANITAKIS, J; STOCKFLETH, E et al.American journal of transplantation (Print). 2008, Vol 8, Num 11, pp 2192-2198, issn 1600-6135, 7 p.Article

Treatment outcome with mTOR inhibitors for metastatic renal cell carcinoma with nonclear and sarcomatoid histologiesVOSS, M. H; BASTOS, D. A; KARLO, C. A et al.Annals of oncology. 2014, Vol 25, Num 3, pp 663-668, issn 0923-7534, 6 p.Article

Tolerability of everolimus-based immunosuppression in maintenance liver transplant recipientsVALLIN, Mélanie; GUILLAUD, Olivier; MORARD, Isabelle et al.Clinical transplantation. 2011, Vol 25, Num 4, pp 660-669, issn 0902-0063, 10 p.Article

High-performance liquid chromatography analysis of a novel small-molecule, anti-cancer drug, Palomid 529, in human and mouse plasma and in mouse tissue homogenatesFAN LIN; SHERRIS, David; BEIJNEN, Jos H et al.Journal of chromatography. B. 2011, Vol 879, Num 32, pp 3823-3831, issn 1570-0232, 9 p.Article

Clinical Outcomes in Kidney Transplant Recipients Receiving Long-Term Therapy With Inhibitors of the Mammalian Target of RapamycinCORTAZAR, F; MOLNARB, M. Z; ISAKOVA, T et al.American journal of transplantation (Print). 2012, Vol 12, Num 2, pp 379-387, issn 1600-6135, 9 p.Article

A review of oral toxicity associated with mTOR inhibitor therapy in cancer patientsMARTINS, Fabiana; DE OLIVEIRA, Marcio Augusto; QIAN WANG et al.Oral oncology (1997). 2013, Vol 49, Num 4, pp 293-298, issn 1368-8375, 6 p.Article

Oral and intravenously administered mTOR inhibitors for metastatic renal cell carcinoma: Pharmacokinetic considerations and clinical implicationsDANESI, Romano; BONI, Joseph P; RAVAUD, Alain et al.Cancer treatment reviews. 2013, Vol 39, Num 7, pp 784-792, issn 0305-7372, 9 p.Article

Primär- und Sekundärprophylaxe von Hauttumoren nach Organtransplantation : Dermatologie und Transplantation = Primary and secondary prevention of skin cancer in organ transplant recipients : Dermatology and TransplantLONSDORF, A. S; BECKER, M. R; STOCKFLETH, E et al.Der Hautarzt. 2010, Vol 61, Num 3, issn 0017-8470, 195-206 [10 p.]Article

Loss of Nephrin Expression in Glomeruli of Kidney-Transplanted Patients Under m-TOR Inhibitor TherapyBIANCONE, L; BUSSOLATI, B; CANTALUPPI, V et al.American journal of transplantation (Print). 2010, Vol 10, Num 10, pp 2270-2278, issn 1600-6135, 9 p.Article

New drug development in digestive neuroendocrine tumorsDURAN, I; SALAZAR, R; CASANOVAS, O et al.Annals of oncology. 2007, Vol 18, Num 8, pp 1307-1313, issn 0923-7534, 7 p.Article

'Old-for-old' : new strategies for renal transplantationARNS, Wolfgang; CITTERIO, Franco; CAMPISTOL, Josep M et al.Nephrology, dialysis, transplantation (Print). 2007, Vol 22, Num 2, pp 336-341, issn 0931-0509, 6 p.Article

MTOR Inhibitors and Calcineurin Inhibitors Do Not Affect Adhesion Molecule Expression of Human Macro-and Microvascular Endothelial CellsLEHLE, Karla; SCHREML, Stephan; KUNZ-SCHUGHART, Leoni A et al.Journal of vascular research. 2008, Vol 45, Num 4, pp 333-342, issn 1018-1172, 10 p.Article

Use of proliferation signal inhibitors in the management of post-transplant malignancies-clinical guidanceCAMPISTOL, Josep M; ALBANELL, Joan; POHANKA, Erich et al.Nephrology, dialysis, transplantation (Print). 2007, Vol 22, issn 0931-0509, i36-i41, SUP1Article